• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2'-氟修饰的硫代磷酸酯寡核苷酸可导致P54nrb和PSF快速降解。

2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.

作者信息

Shen Wen, Liang Xue-Hai, Sun Hong, Crooke Stanley T

机构信息

Department of Core Antisense Research, ISIS Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA.

Department of Core Antisense Research, ISIS Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA

出版信息

Nucleic Acids Res. 2015 May 19;43(9):4569-78. doi: 10.1093/nar/gkv298. Epub 2015 Apr 8.

DOI:10.1093/nar/gkv298
PMID:25855809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4482069/
Abstract

Synthetic oligonucleotides are used to regulate gene expression through different mechanisms. Chemical modifications of the backbone of the nucleic acid and/or of the 2' moiety of the ribose can increase nuclease stability and/or binding affinity of oligonucleotides to target molecules. Here we report that transfection of 2'-F-modified phosphorothioate oligonucleotides into cells can reduce the levels of P54nrb and PSF proteins through proteasome-mediated degradation. Such deleterious effects of 2'-F-modified oligonucleotides were observed in different cell types from different species, and were independent of oligonucleotide sequence, positions of the 2'-F-modified nucleotides in the oligonucleotides, method of delivery or mechanism of action of the oligonucleotides. Four 2'-F-modified nucleotides were sufficient to cause the protein reduction. P54nrb and PSF belong to Drosophila behavior/human splicing (DBHS) family. The third member of the family, PSPC1, was also reduced by the 2'-F-modified oligonucleotides. Preferential association of 2'-F-modified oligonucleotides with P54nrb was observed, which is partially responsible for the protein reduction. Consistent with the role of DBHS proteins in double-strand DNA break (DSB) repair, elevated DSBs were observed in cells treated with 2'-F-modified oligonucleotides, which contributed to severe impairment in cell proliferation. These results suggest that oligonucleotides with 2'-F modifications can cause non-specific loss of cellular protein(s).

摘要

合成寡核苷酸可通过不同机制用于调控基因表达。核酸主链和/或核糖2'部分的化学修饰可提高寡核苷酸对靶分子的核酸酶稳定性和/或结合亲和力。在此我们报告,将2'-F修饰的硫代磷酸酯寡核苷酸转染到细胞中可通过蛋白酶体介导的降解降低P54nrb和PSF蛋白的水平。在来自不同物种的不同细胞类型中均观察到2'-F修饰寡核苷酸的这种有害作用,且其与寡核苷酸序列、寡核苷酸中2'-F修饰核苷酸的位置、递送方法或寡核苷酸的作用机制无关。四个2'-F修饰核苷酸就足以导致蛋白质减少。P54nrb和PSF属于果蝇行为/人类剪接(DBHS)家族。该家族的第三个成员PSPC1也被2'-F修饰的寡核苷酸所降低。观察到2'-F修饰的寡核苷酸与P54nrb优先结合,这部分导致了蛋白质减少。与DBHS蛋白在双链DNA断裂(DSB)修复中的作用一致,在用2'-F修饰的寡核苷酸处理的细胞中观察到DSB升高,这导致细胞增殖严重受损。这些结果表明,具有2'-F修饰的寡核苷酸可导致细胞蛋白质的非特异性丧失。

相似文献

1
2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.2'-氟修饰的硫代磷酸酯寡核苷酸可导致P54nrb和PSF快速降解。
Nucleic Acids Res. 2015 May 19;43(9):4569-78. doi: 10.1093/nar/gkv298. Epub 2015 Apr 8.
2
Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.氟代修饰 5-10-5 间隙寡核苷酸硫代磷酸酯在小鼠中的急性肝毒性与细胞内蛋白结合和 DBHS 蛋白丢失相关。
Nucleic Acids Res. 2018 Mar 16;46(5):2204-2217. doi: 10.1093/nar/gky060.
3
Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF.一致性PP1结合基序调节类固醇受体辅调节因子p54nrb和PSF的转录共抑制及可变RNA剪接活性。
Mol Endocrinol. 2011 Jul;25(7):1197-210. doi: 10.1210/me.2010-0517. Epub 2011 May 12.
4
Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translation.NEAT1长链非编码RNA的缺失通过释放被隔离的P54nrb和PSF来减轻核仁应激,以促进c-Myc的翻译。
PLoS One. 2017 Mar 13;12(3):e0173494. doi: 10.1371/journal.pone.0173494. eCollection 2017.
5
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.通过调节与细胞蛋白的相互作用,使硫代磷酸酯与烷基膦酸酯键在特定部位进行替换,增强了 gapmer ASO 的治疗谱。
Nucleic Acids Res. 2019 Jun 20;47(11):5465-5479. doi: 10.1093/nar/gkz247.
6
Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila NONA/BJ6.HeLa细胞p54nrb的纯化及cDNA克隆,p54nrb是一种核蛋白,具有两个RNA识别基序,与人类剪接因子PSF和果蝇NONA/BJ6具有广泛同源性。
Nucleic Acids Res. 1993 Aug 25;21(17):4085-92. doi: 10.1093/nar/21.17.4085.
7
Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.核酸结合蛋白影响硫代磷酸酯反义寡核苷酸的亚细胞分布。
Nucleic Acids Res. 2017 Oct 13;45(18):10649-10671. doi: 10.1093/nar/gkx709.
8
Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation.人 NONO 和核小体蛋白成分 1 异二聚体的结构及其在亚核小体形成中的作用分析。
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4846-50. doi: 10.1073/pnas.1120792109. Epub 2012 Mar 13.
9
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.热休克蛋白90(Hsp90)与含有疏水性2'-修饰的硫代磷酸酯寡核苷酸相互作用,并增强反义活性。
Nucleic Acids Res. 2016 May 5;44(8):3892-907. doi: 10.1093/nar/gkw144. Epub 2016 Mar 3.
10
Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.硫代磷酸寡核苷酸与 RNase H1 的结合会导致蛋白质构象发生变化,并改变 RNase H1 与其他蛋白质的相互作用。
Nucleic Acids Res. 2021 Mar 18;49(5):2721-2739. doi: 10.1093/nar/gkab078.

引用本文的文献

1
The Progress and Evolving Trends in Nucleic-Acid-Based Therapies.基于核酸的疗法的进展与发展趋势
Biomolecules. 2025 Mar 5;15(3):376. doi: 10.3390/biom15030376.
2
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease.反义寡核苷酸药物在肌萎缩侧索硬化症和亨廷顿病中的应用。
Transl Neurodegener. 2025 Jan 21;14(1):4. doi: 10.1186/s40035-025-00466-9.
3
A review of the complex interplay between chemoresistance and lncRNAs in lung cancer.肺癌中化疗耐药与长链非编码RNA之间复杂相互作用的综述

本文引用的文献

1
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.鉴定和表征与硫代磷酸酯键连接的寡核苷酸结合的细胞内蛋白质。
Nucleic Acids Res. 2015 Mar 11;43(5):2927-45. doi: 10.1093/nar/gkv143. Epub 2015 Feb 20.
2
Double-strand break repair deficiency in NONO knockout murine embryonic fibroblasts and compensation by spontaneous upregulation of the PSPC1 paralog.NONO基因敲除小鼠胚胎成纤维细胞中的双链断裂修复缺陷以及PSPC1旁系同源物的自发上调补偿作用
Nucleic Acids Res. 2014 Sep;42(15):9771-80. doi: 10.1093/nar/gku650. Epub 2014 Aug 6.
3
Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures.
J Transl Med. 2024 Dec 5;22(1):1109. doi: 10.1186/s12967-024-05877-2.
4
Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells.甲磺酸酯和丁磺酸酯磷酰胺酸酯反义寡核苷酸在无辅助及PSMA介导下进入前列腺癌细胞的构效关系研究
Front Chem. 2024 Mar 4;12:1342178. doi: 10.3389/fchem.2024.1342178. eCollection 2024.
5
RNA interference in the era of nucleic acid therapeutics.核酸治疗时代的RNA干扰
Nat Biotechnol. 2024 Mar;42(3):394-405. doi: 10.1038/s41587-023-02105-y. Epub 2024 Feb 26.
6
Profiling the interactome of oligonucleotide drugs by proximity biotinylation.通过邻近生物素化技术对寡核苷酸药物的相互作用组进行分析。
Nat Chem Biol. 2024 May;20(5):555-565. doi: 10.1038/s41589-023-01530-z. Epub 2024 Jan 17.
7
Advances in modification and delivery of nucleic acid drugs.核酸药物的修饰和递送技术的进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Aug 25;52(4):417-428. doi: 10.3724/zdxbyxb-2023-0130.
8
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics.siRNA 治疗药物的内在毒性和传递介导毒性的整体分析。
Adv Drug Deliv Rev. 2023 Oct;201:115052. doi: 10.1016/j.addr.2023.115052. Epub 2023 Aug 9.
9
DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.DNA 酶:拓展核酸治疗的潜力。
Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21.
10
Chemically modified aptamers for improving binding affinity to the target proteins enhanced non-covalent bonding.用于提高与靶蛋白结合亲和力的化学修饰适配体增强了非共价键合。
Front Cell Dev Biol. 2023 Feb 23;11:1091809. doi: 10.3389/fcell.2023.1091809. eCollection 2023.
硫代磷酸酯寡核苷酸可以取代NEAT1 RNA并形成核旁斑样结构。
Nucleic Acids Res. 2014 Jul;42(13):8648-62. doi: 10.1093/nar/gku579. Epub 2014 Jul 10.
4
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.TCP1复合蛋白与硫代磷酸酯寡核苷酸相互作用,并可在哺乳动物细胞的寡核苷酸诱导核小体中共定位。
Nucleic Acids Res. 2014 Jul;42(12):7819-32. doi: 10.1093/nar/gku484. Epub 2014 May 26.
5
Single-stranded siRNAs activate RNAi in animals.单链 siRNAs 在动物中激活 RNAi。
Cell. 2012 Aug 31;150(5):883-94. doi: 10.1016/j.cell.2012.08.014.
6
Adenosine modification may be preferred for reducing siRNA immune stimulation.腺苷修饰可能更适合降低 siRNA 的免疫刺激。
Nucleic Acid Ther. 2012 Jun;22(3):205-10. doi: 10.1089/nat.2011.0334. Epub 2012 Apr 20.
7
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing.合成寡核苷酸募集 ILF2/3 到 RNA 转录本以调节剪接。
Nat Chem Biol. 2012 Apr 15;8(6):555-61. doi: 10.1038/nchembio.939.
8
Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation.人 NONO 和核小体蛋白成分 1 异二聚体的结构及其在亚核小体形成中的作用分析。
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4846-50. doi: 10.1073/pnas.1120792109. Epub 2012 Mar 13.
9
RNA therapeutics: beyond RNA interference and antisense oligonucleotides.RNA 疗法:超越 RNA 干扰和反义寡核苷酸。
Nat Rev Drug Discov. 2012 Jan 20;11(2):125-40. doi: 10.1038/nrd3625.
10
Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response.Matrin 3 和 SFPQ/NONO 在 DNA 损伤反应中的作用。
Cell Cycle. 2010 Apr 15;9(8):1568-76. doi: 10.4161/cc.9.8.11298.